Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M187Revenue (TTM) $M45.7Net Margin (%)-9.5Altman Z-Score11.4
Enterprise Value $M145EPS (TTM) $-0.2Operating Margin %-10.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-9.6Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio6.0Cash flow > EarningsY
Price/Sales4.15-y EBITDA Growth Rate %--Current Ratio8.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-116.6ROA % (ttm)-2.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-3.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M22.9ROIC % (ttm)-5.7Gross Margin Increase y-yY

Gurus Latest Trades with ENZY

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ENZY is held by these investors:



ENZY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about ENZY :

Quarterly/Annual Reports about ENZY:

    News about ENZY:

    Articles On GuruFocus.com
    Enzymotec Ltd. to Present at the Jefferies 2017 Global Healthcare Conference May 25 2017 
    Enzymotec to Report First Quarter 2017 Financial Results May 03 2017 
    VAYA Pharma Introduces New Three-Month Supply of Vayarin® and Vayacog® Medical Foods May 02 2017 
    Neptune and Enzymotec Reach Patent Agreement Ending All Litigation Apr 03 2017 
    Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016 Mar 16 2017 
    Enzymotec Ltd. Calls an Extraordinary General Meeting of Shareholders Mar 10 2017 
    Enzymotec Ltd. Announces the Appointment of Erez Israeli as President and CEO Mar 09 2017 
    Julian Robertson Adds to Multiple Positions in 3rd quarter Dec 20 2016 
    Julian Robertson Cuts Half of Stake in Paulson-Backed Company Jul 01 2016 
    Tiger Management Founder Julian Robertson Ups Stake in Enzymotec Dec 07 2015 

    More From Other Websites
    Enzymotec Ltd. to Present at the Jefferies 2017 Global Healthcare Conference May 25 2017
    Enzymotec misses 1Q profit forecasts May 17 2017
    Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial Results May 17 2017
    Investor Network: Enzymotec Ltd. to Host Earnings Call May 17 2017
    Enzymotec to Report First Quarter 2017 Financial Results May 03 2017
    VAYA Pharma Introduces New Three-Month Supply of Vayarin® and Vayacog® Medical Foods May 02 2017
    Enzymotec Ltd. :ENZY-US: Earnings Analysis: Q4, 2016 By the Numbers : April 3, 2017 Apr 03 2017
    Neptune and Enzymotec Reach Patent Agreement Ending All Litigation Apr 03 2017
    Neptune and Enzymotec reach Patent Agreement Ending All Litigation Apr 03 2017
    Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016 Mar 16 2017
    Enzymotec Ltd. Calls an Extraordinary General Meeting of Shareholders Mar 10 2017
    Enzymotec Ltd. Announces the Appointment of Erez Israeli as President and CEO Mar 09 2017
    Enzymotec reports 4Q loss Feb 22 2017
    Does Enzymotec Ltd (ENZY) Stack Up To Its Peers In This Metric? Dec 15 2016
    What Makes Enzymotec (ENZY) a Strong Sell? Dec 12 2016
    Edited Transcript of ENZY earnings conference call or presentation 9-Aug-16 12:30pm GMT Aug 19 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)